Metacrine to Present Phase 1 Results of MET409, an Optimized Next Generation FXR Agonist at The International Liver Congress (EASL) 2019
April 03, 2019 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and...
Breathtec Announces Name Change to Algernon Pharmaceuticals
February 14, 2019 07:00 ET
|
Breathtec Biomedical Inc.
New corporate identity aligned with the Company's main strategy to be a global leader in the treatment of liver disease (NASH), chronic kidney disease and inflammatory bowel disease. The company's...
Capital Digestive Care Taps Ramsey Daher, MD for Its Metro Offices
February 14, 2019 06:02 ET
|
Capital Digestive Care
Silver Spring, MD, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Capital Digestive Care welcomes Ramsey Daher, MD to its growing practice. Dr. Daher is now seeing patients at the company’s K Street, NW office...
Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference
February 13, 2019 07:00 ET
|
Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI)...
Nash Pharmaceuticals Announces Positive Pre-Clinical Results For Its Lead Compound NP-178 in a New Study for Crohn’s Disease
December 03, 2018 07:00 ET
|
Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI)...
Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud
November 07, 2018 09:42 ET
|
Biomerica, Inc.
Eliminating positive foods identified by Biomerica’s diagnostic product showed statistically significant improvements (p<0.05) in both Quality of Life (FDA Instrument) and disease activity (Mayo...
IBD Breakout Stocks Index Licensed by Innovator Capital Management Forms Basis for Latest ETF Listing
September 13, 2018 08:00 ET
|
Investor's Business Daily
LOS ANGELES, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Investor’s Business Daily (IBD), a leading financial news and research organization, today announced that Innovator Capital Management, LLC, has...
Breathtec Provides Nash Pharmaceuticals’ Plans for Next Year
September 13, 2018 07:00 ET
|
Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the “Company”) is pleased to provide details on Nash...
Why You Could Have Celiac Disease Without Knowing It
September 12, 2018 12:49 ET
|
Capital Digestive Care
Rockville, MD, Sept. 12, 2018 (GLOBE NEWSWIRE) -- By Brian Ciampa, MD Celiac disease is an autoimmune disorder affecting at least three million Americans, but it can be a difficult illness to pin...
Metacrine Appoints Hubert Chen, M.D. as Chief Medical Officer and Andrew Guggenhime to the Board of Directors
September 06, 2018 07:30 ET
|
Metacrine, Inc.
SAN DIEGO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., a biotechnology company developing therapies to benefit patients with liver and gastrointestinal diseases (GI), today announced the...